Collectively, a λ phage vaccine targeting ASPH combined with a checkpoint inhibitor successfully initiates antigen specific CD8+T and B cell-mediated cellular and humoral immunity in HCC and TNBC. This evidence concerns the gene CD8A and hepatocellular carcinoma.